Article info
PDFPapers
Public health ethics
Paper
Widening the debate about conflict of interest: addressing relationships between journalists and the pharmaceutical industry
- Correspondence to Dr Wendy Lipworth, AGSM Building, University of New South Wales, Sydney, NSW 2052, Australia; w.lipworth{at}unsw.edu.au
Citation
Widening the debate about conflict of interest: addressing relationships between journalists and the pharmaceutical industry
Publication history
- Received September 26, 2011
- Revised December 5, 2011
- Accepted February 13, 2012
- First published March 19, 2012.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- Conflicted and confused? Health harming industries and research funding in leading UK universities
- Criteria for evaluating tobacco control research funding programs and their application to models that include financial support from the tobacco industry
- Ethics and Technology Transfer
- Views of health journalists, industry employees and news consumers about disclosure and regulation of industry-journalist relationships: an empirical ethical study
- Working with the private sector: the need for institutional guidelines
- Has the hunt for conflicts of interest gone too far? No
- Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption?
- Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform
- US research agency halves threshold for reporting financial conflicts of interest
- Commercial interests, transparency, and independence: a call for submissions